TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06930755: Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer

Sponsor: Nerviano Medical Sciences · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 24 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$848,232

Rescue Site Savings

+$565,488

Unlock Full NCT06930755 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06930755 Rescue Dossier →